

The BUCHI Melting Point M-565 is a fully automatic melting point apparatus that combines pharmacopoeia-compliant measurement with digital image processing for objective, reproducible results. Automatic detection of melting, boiling and cloud points removes operator subjectivity, while integrated video recording preserves the complete thermal event for documentation and audit trails - ideal for regulated pharmaceutical QC environments. Up to three capillary samples are analysed in parallel across a 10 to 400 °C range, supporting both rapid identity screening and high-precision certification work on the same instrument. The high-resolution colour display and 2.5x magnifier let the operator confirm the automatic reading visually, and the optional Sample Loader M-569 automates capillary filling to further reduce variability and manual effort. Full compliance with European, USP and Japanese Pharmacopoeia methods makes the M-565 the reference instrument for GMP identity testing, method validation and stability studies in modern pharmaceutical, contract-research and fine-chemical laboratories. Because the entire measurement is recorded on video, results can be reviewed, re-evaluated or audited long after the sample is discarded, supporting traceability requirements and reducing the need to repeat measurements.
Key specifications:
• Temperature range: 10 to 400 °C
• Sample capacity: 3 capillaries analysed in parallel
• Detection method: fully automatic via digital image analysis
• Video recording of the entire measurement
• Optional Sample Loader M-569 for automated capillary filling
• Large high-resolution colour display with 2.5x magnifier
• Fully compliant with European, USP and Japanese Pharmacopoeia methods
Applications:
• Regulated pharmaceutical QC (GMP identity testing)
• Contract research and academic laboratories
• Fine chemical and specialty compound characterisation
• Method validation and stability studies
• Objective purity assessment of new chemical entities
Premium quality laboratory equipment and services.